Searched for
SIRNA
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...- Novartis bets big on India; looks to grow beyond cost arbitrage to high-value innovationNovartis is significantly expanding its biomedical research and drug development operations in India, positioning it as a key global hub ou...
- From pharmacy to innovation hub: Why India needs a regulatory revolution in biotechIndia aims to transition from a global pharmacy to an innovation hub by reforming its regulatory landscape. The focus is on AI-powered appr...
- Seeing good demand for biologics manufacturing: Syngene CEO Jonathan HuntIn an interview to ET, Jonathan Hunt, CEO and MD of Syngene said the company has spare capacity and is also investing on expansion of micro...
- Nobel laureate Roger Kornberg to help India develop dengue, TB drugsKornberg said that after processing necessary documents, his laboratory at Stanford School of Medicine, will transfer RNA molecules to be t...
- Biocon, Quark get DCGI nod for trials of new eye disease drugBiocon Chairperson Kiran Mazumdar Shaw said, "India has a significant number of NAION patients and we are pleased to be the first one to pr...
- Nanoneedles can generate new blood vesselsThe researchers are now aiming to develop a material like a flexible bandage that can incorporate the nanoneedles.
- Biocon shares soar 12 pc as co inks pact with Quark PharmaBiocon's scrip ended the day at Rs 437.35, a gain of 11.38% on the BSE. During the day, the scrip surged 14.83% to Rs 450.90 -- its 52-week...
- Biocon inks licensing pact with US-based Quark PharmaBiocon today said it has inked a pact with Quark Pharmaceuticals, Inc to develop a range of siRNA (small interfering RNA) based novel thera...
- Actis signs pact to set up biotech city in MalaysiaActis has set up Malaysia Telesta Diagnostics centre focusing on computer-aided diagnosis for breast cancer. Telesta is also willing for a ...
- Big Pharma seeks biotech dose to spur growthVincent Aita of Kilkenny Capital Management says he picks biotechnology stocks on their potential as takeover targets.
- Merck to acquire biotech co Sirna for $1.1bn all cashPharmaceutical company Merck said it agreed to pay an eye-popping $1.1bn to buy Sirna Therapeutics, a tiny biotechnology firm developing dr...
Load More
